About The Event
SCOPE is fast approaching and we couldn't be more excited to exhibit our solutions.  If you are planning on attending, please stop by our booth #303 and 305.
When:
January 24-26, 2017
Where:
Hyatt Regency Miami
Miami, FL
www.scopesummit.com
Booth #303 and 305
Wednesday, January 25 | 11:40 am
Communication for Strategic Partnerships:  Establishing Relationships to Enable Better Negotiating and Contracting
Session in the Managing Late Stage Research, Observational Studies Registries Track
Gregory Skalicky
Chief Enterprise Business Officer,
inVentiv Health Clinical
Gregory Skalicky, Chief Enterprise Business Officer at inVentiv Health Clinical Division, is responsible for enhancing the company's global market position. As the senior executive leading the global sales strategy across the Early Stage, Phases II-IV and Strategic Resourcing businesses, Greg assists clients in identifying the specific therapeutic expertise and skills needed to achieve success in clinical development and post-market research. Greg has worked in the pharmaceutical industry for nearly 20 years in both clinical operations and business development. He began his career at inVentiv Health in 1997, with responsibility for developing strategic relationships. Greg is an active member of the clinical roundtable network, Linking Leaders and was recently selected as a PharmaVoice Top 100 most inspirational and innovative life-science industry professionals of 2016.

Wednesday, January 25 | 12:10 pm

Leveraging Educational Materials in the Site and Patient Engagement in Observational Research
Session in the Managing Late Stage Research, Observational Studies Registries Track
Heather Gartman
Regional Managing Director, Public Relations
Group, inVentiv Health
Heather has nearly three decades of experience in public relations and marketing communications for healthcare clients including pharmaceutical and device manufacturers, patient advocacy groups, medical societies, trade associations and healthcare non-profits. As the leader of inVentiv Health’s patient engagement initiative, Heather counsels biopharmaceutical companies on successfully engaging patient and community voices at all stages of the development process from early stage clinical trials through to product launch.
Julie Randolph
Director,
Late Stage
Julie Randolph, PhD, MPH, has over twenty years of experience in healthcare research in clinical and public health arenas. As a Director with inVentiv Health, Julie is responsible for implementing and overseeing observational studies while taking an active role in client relationship development and collaborative management. Throughout her late-phase experience, Julie has led numerous teams through innovative study design, development, and implementation activities for global research studies across several clinical therapeutic areas.
Thursday, January 26 | 9:55 am
The "How" and "Why" of Leveraging Real World Data for Clinical and Observational Research
Leveraging Existing Data in Clinical Trials and Observational Research Track
Amy Ryan
M.S., Director of Biostatistics, Phase IV
Operations, inVentiv Health
Amy Ryan M.S., Director of Biostatistics, Late Stage, is a biostatistician with 20+ years of experience in pharmaceutical and health outcomes research, 15 of those years in Late Stage research. She has worked in many therapeutic areas including cardiovascular disease, diabetes, oncology, obesity, women’s health and autoimmune disorders. Her work has spanned both prospective research, including all phases of clinical trials, as well as retrospective analyses on large scale claims, hospital billing and EMR databases.
inVentiv Health by the Numbers
> 15,000 inVentiv Health Experts
helping global clients realize their goals in clinical development and commercialization.
> 90 Countries  
in which inVentiv Health has the ability to support clients.
550 Global Pharmaceutical Companies
have turned to inVentiv Health for expertise, skills and insight.
inVentiv Health is one of the nation’s largest providers of direct-to-patient communcations with real-time access to 9 years of data that includes:
30,000 Pharmacies
194M+ Health Consumers
285,000 Physicians
2.2 Billion Annual Prescriptions
60% of all retail prescriptions
across 35 chains
In the past 5 years, inVentiv Health has helped to develop or commercialize:
Approved by the FDA
81%
Novel New Drugs
79%
Novel New Oncology Drugs
88%
Novel New Central Nervous System Drugs
Approved by the EMA
70%
Products Granted Marketing Authorization
84%
Oncology Drugs
70%
Central Nervous System Drugs
Schedule a Meeting Now
© 2017 inVentiv Health. All Rights Reserved.
Terms of Use